Nuveen Asset Management, LLC Assembly Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $803,905 - $964,686	-211,554 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $4,944 - $7,571	-1,142 Reduced 0.54%	211,554 $973,000
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $549,209 - $1.95 Million	-112,774 Reduced 34.65%	212,696 $1.29 Million
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $1.57 Million - $2.82 Million	-104,247 Reduced 24.26%	325,470 $5.35 Million
Q2 2020 Aug 14, 2020	SELL	$14.57 - $23.96 $1.05 Million - $1.72 Million	-71,988 Reduced 14.35%	429,717 $10 Million
Q1 2020 May 14, 2020	BUY	$10.27 - $21.23 $1.53 Million - $3.17 Million	149,386 Added 42.4%	501,705 $7.44 Million
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $1.13 Million - $3.23 Million	135,662 Added 62.62%	352,319 $7.21 Million
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $552,544 - $833,032	-56,210 Reduced 20.6%	216,657 $2.13 Million
Q2 2019 Aug 15, 2019	BUY	$12.9 - $20.8 $3.52 Million - $5.68 Million	272,867 New	272,867 $3.68 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.